Johnson & Johnson said it’s delaying the rollout of its Covid-19 vaccine in Europe after U.S. regulators paused immunizations with the shot pending a review of rare blood clots.
Johnson & Johnson said it’s delaying the rollout of its Covid-19 vaccine in Europe after U.S. regulators paused immunizations with the shot pending a review of rare blood clots.